TD Cowen lowered the firm’s price target on Old Dominion (ODFL) to $183 from $188 and keeps a Hold rating on the shares. The firm noted they ...

TD Cowen analyst Steve Scala maintained a Buy rating on AstraZeneca (AZN – Research Report) today. The company’s shares closed yesterday at ...

Fintel reports that on February 5, 2025, TD Cowen initiated coverage of Palvella Therapeutics (NasdaqCM:PVLA) with a Buy ...

Seeing “growth on hiatus,” Mr. Bir reduced his own forecast for 2025 and 2026 “with revisions mainly for longer lease-up ...

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry Genetics ...

Fintel reports that on February 4, 2025, TD Cowen downgraded their outlook for Napco Security Technologies (NasdaqGS:NSSC) ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

OSI Systems, Inc. (NASDAQ: OSIS), today announced that it will present at the TD Cowen 46th Annual Aerospace & Defense Conference on Wednesday, February 12, 2025, at 10:45 AM ET.

Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...

The transportation sector will be impacted by Trump's new tariff regime. Parcel consolidators and freight forwarders - like ...